Evidence map›Paper›PMID 18396125›Full record

ArticleBone2008

Modulation of extracellular matrix protein phosphorylation alters mineralization in differentiating chick limb-bud mesenchymal cell micromass cultures.

Adele L Boskey, Stephen B Doty, Valery Kudryashov, Philipp Mayer-Kuckuk, Rani Roy, Itzhak Binderman

Open access · greenAbstract read
In one paragraph

Article in Bone, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 39 citations in OpenAlex.

  1. The role of bone sialoprotein in bone healing.Journal of structural biology · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adele L BoskeyHospital for Special Surgery, 535 E 70th Street, New York, NY 10021, USA. boskeya@hss.edu
Stephen B Doty
Valery Kudryashov
Philipp Mayer-Kuckuk
Rani Roy
Itzhak Binderman
Hospital for Special Surgery · US

Funding

TRABECULAR BONE ADAPTATION TO MECHANICAL LOADINGP30AR046121 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI DOTY, STEPHEN BRUCE · 1999 to 2010
$5.5M
IN VIVO INITIATION OF BIOLOGICAL CALCIFICATIONR01AR037661 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI BOSKEY, ADELE L · 1987 to 2009
$2.8M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR012538 · NCRR · HOSPITAL FOR SPECIAL SURGERY · PI BOSKEY, ADELE L · 1997 to 1997
–
NCRR NIH HHS C06 RR012538NCRR NIH HHS C06-RR12538-01NIAMS NIH HHS AR037661NIAMS NIH HHS AR046121NIAMS NIH HHS P30 AR046121NIAMS NIH HHS R01 AR037661
6 · The paper itself

Abstract

Protein phosphorylation and dephosphorylation are important regulators of cellular and extracellular events. The purpose of this study was to define how these events regulate cartilage matrix calcification in a cell culture system that mimics endochondral ossification. The presence of casein kinase II (CK2), an enzyme known to phosphorylate matrix proteins, was confirmed by immunohistochemistry. The importance of phosphoprotein phosphorylation and dephosphorylation was examined by comparing effects of inhibiting CK2 or phosphoprotein phosphatases on mineral accretion relative to untreated mineralizing controls. Specific inhibitors were added to differentiating chick limb-bud mesenchymal cell micromass cultures during the development of a mineralized matrix at the times of cell differentiation, proliferation, formation of the mineralized matrix, or proliferation of the mineral crystals. The mineralizing media for these cultures contained 4 mM inorganic phosphate and no organic-phosphate esters; control cultures had 1 mM inorganic phosphate. Mineralization was monitored based on (45)Ca uptake and infrared characterization of the mineral; cell viability was assessed by three independent methods. Treatments that caused cell toxicity were excluded from the analysis. Inhibition of CK2 activity with apigenin or CK2 inhibitor II reduced the rate of mineral deposition, but did not block mineral accretion. Effects were greatest during the time of mineralized matrix formation. Inhibition of phosphoprotein phosphatase activities with okadaic acid, calyculin A, and microcystin-LR, at early time points also markedly inhibited mineral accretion. Inhibition after mineralization had commenced increased the mineral yield. Levamisole, an alkaline phosphatase inhibitor, had no effect on mineral accretion in this system, suggesting the involvement of other phosphatases. Adding additional inorganic phosphate to the inhibited cultures after mineralization had started, but not earlier, reversed the inhibition indicating that the phosphatases were, in part, providing a source of inorganic phosphate. To characterize the roles of specific phosphoproteins blocking studies were performed. Blocking with anti-osteopontin antibody confirmed osteopontin's previously reported role as a mineralization inhibitor. Blocking antibodies to bone sialoprotein added from day 9 or on days 9 and 11 retarded mineralization, supporting its role as a mineralization nucleator. Antibodies to osteonectin slightly stimulated early mineralization, but had no effect after the time that initial mineral deposition occurs. Taken together, the results of this study demonstrate the importance of the phosphorylation state of extracellular matrix proteins in regulating mineralization in this culture system.

Indexed as

Calcification, PhysiologicCartilageAnimalsApigeninCasein Kinase IICell Culture TechniquesCell DifferentiationChick EmbryoEnzyme InhibitorsExtracellular MatrixExtracellular Matrix ProteinsMesenchymal Stem CellsPhosphorylationApigeninCasein Kinase IIEnzyme InhibitorsExtracellular Matrix Proteins

Identifiers

PMID18396125
PMCPMC2442476
OpenAlexW2112966935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.